I personally get out of biotecs if I can’t see they have enough capital to operate for the 12 mts ahead without taking into account any forecasts on what sales growths or approvals might eventuate . So many companies fall just short of getting their product to market due to underestimating what capital and how long it will take
Ann: Admedus Secures Strategic Investor, page-376
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.43 |
Change
-0.120(1.04%) |
Mkt cap ! $241.6M | |||
| Open | High | Low | Value | Volume |
| $11.58 | $11.58 | $11.17 | $196.0K | 17.23K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 30 | $11.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.50 | 200 | 1 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |